The Movember Foundation is proud to report that the findings from this funded research project will have considerable implications for men around the world navigating through their prostate cancer treatment journey.
This research, lead by Professor Robert Bristow of the Princess Margaret Cancer Centre in Toronto, has discovered that men have a genetic “fingerprint” within their cancer cells that will basically tell them whether or not the cells have escaped the prostate gland.
This means that patients who have aggressive prostate cancer have a unique genetic fingerprint, and knowing this will now allow doctors to build a more tailored and intensified treatment plan for those who need it. This personalised medicine approach will improve cure rates in patients with aggressive prostate cancer but also allow doctors to not over treat patients who do not have aggressive prostate cancer.
Canadian researchers will work with other countries to validate the test over the next two to three years in a larger, more diverse group of patients to ensure it will successfully work in hospitals worldwide. If validated, this new test for prostate cancer can be turned around in three days and will inform doctors which patients will need more or less invasive treatments.
This research proves the considerable impact that Movember funds are having, the results of which are benefitting hundreds of thousands of men and their families around the world.
It’s not too late to help us make a difference. Sign up today and donate to your local Mo Bros and Mo Sistas.
Thank you to Mo Bros and Mo Sistas and all our donors who have come together and trusted us with their donations. Together, we are truly changing the face of men’s health.
Click here to view the program report card.
Click here to view the program report card.
